Medical Treatment of Early-Enamel Carious Lesion Using Different Remeneralizing Agents
Enamel Caries
About this trial
This is an interventional treatment trial for Enamel Caries focused on measuring Enamel remineralization, Randomized Clinical Trial, Experimental Tricalcium silicate, Sillver diamine flouride-potassium iodide
Eligibility Criteria
Inclusion Criteria:
- Patients with early enamel lesions (ICDAS score 1 and 2).
- Patients with normal occlusion .
- Patients must have a good oral hygiene
- patients free from any systemic diseases and don't receive any medication
Exclusion Criteria:
- smoker patients
- pregnant females
- patients with bad oral hygiene
- patients with enamel defects ( Amelogenesis Imperfecta, fluorosis, cracks or any developmental defects)
Sites / Locations
- Kareem Hamdi
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
silver diamine fluoride-potassium iodide SDF-KI (riva star)
casein phosphopeptide amorphous calcium phosphate CPP-ACP(tooth mousse)
Experimental tricalcium silicate
SDF-KI was applied once as a professional application over the early enamel lesions in cervical third of the buccal surface of molar teeth.
CPP-ACP cream was applied twice daily according to manufacturer's instructions over the early enamel lesions in cervical third of the buccal surface of molar teeth.
Experimental tricalcium silicate paste was applied twice daily over the early enamel lesions in cervical third of the buccal surface of molar teeth